TY  - GEN
AU  - Holmes,Frankie Ann
AU  - Espina,Virginia
AU  - Liotta,Lance A
AU  - Nagarwala,Yasir M
AU  - Danso,Michael
AU  - McIntyre,Kristi J
AU  - Osborne,Cynthia R C
AU  - Anderson,Thomas
AU  - Krekow,Lea
AU  - Blum,Joanne L
AU  - Pippen,John
AU  - Florance,Allison
AU  - Mahoney,Janine
AU  - O'Shaughnessy,Joyce A
TI  - Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling
SN  - 1756-0500
PY  - 2014///0714
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Autophagy
KW  - Biomarkers, Pharmacological
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Carcinoma, Ductal, Breast
KW  - Drug Administration Schedule
KW  - Female
KW  - Forkhead Box Protein O1
KW  - Forkhead Transcription Factors
KW  - genetics
KW  - Gene Expression Regulation, Neoplastic
KW  - drug effects
KW  - Humans
KW  - Lapatinib
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - methods
KW  - PTEN Phosphohydrolase
KW  - Paclitaxel
KW  - Phosphatidylinositol 3-Kinases
KW  - Phosphorylation
KW  - Quinazolines
KW  - Receptor, ErbB-2
KW  - antagonists & inhibitors
KW  - STAT5 Transcription Factor
KW  - Signal Transduction
KW  - Trastuzumab
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1756-0500-6-507
ER  -